Allogene Therapeutics, a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for cancer and autoimmune disease, announced that Benjamin...
ImaginAb, Inc., announces that it has entered into an agreement to sell a pipeline of next-generation therapeutic candidates, proprietary novel biologics technology platform, and...
BD a leading global medical technology company, and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, announced a framework collaboration agreement...
AbbVie and Neomorph, announced a collaboration and option-to-license agreement to develop novel molecular glue degraders for multiple targets across oncology and immunology.
Molecular glue degraders...
Charles River Laboratories International, Inc. and Akron Bio, a leading supplier of critical materials and services for advanced therapies, announced the integration of Akron’s...
